All patients developed a protective antibody response to at least eight pneumococcal serotypes.
Availability of Apremilast in US for Pediatric Patients Opens Avenues for Expanded Treatment Options and Oral Therapy
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
DPCP Immunotherapy Yields 61.8% Hair Regrowth Rate in Pediatric Alopecia Areata
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Q&A: Biologic Therapies in Pediatric Dermatology - Vaccines, Adverse Effects, and Personalized Care
Pediatric Dermatology Highlights in July